20 C
Guwahati
Friday, November 15, 2024

Social activist Pranobjit Chaliha undergoes treatment at Sivasagar Civil Hospital

- Advertisement -
- Advertisement -

HT Correspondent

SIVASAGAR, Aug 25: Pranobjit Chaliha, a revered social activist, an unwavering leader of the Assam Movement, Aikya Mancha supremo, and a prominent advocate of Assamese nationalism, is currently receiving medical care for chronic pulmonary obstructions in the Intensive Care Unit (ICU) of Sivasagar Civil Hospital.

- Advertisement -

According to his wife Rakajyoti Chaliha, Pranobjit Chaliha, also known as Romuda, was admitted to the ICU due to a severe fever and a drop in his oxygen levels a couple of days ago. Dr Makhan Kalita, the hospital’s superintendent, confirmed that while his condition is now stable, he will require a few more days of observation before he can be discharged.

Numerous supporters and followers of Pranobjit Chaliha have been flocking to the hospital’s ICU to inquire about his well-being and show their support for their esteemed leader during this time.

- Advertisement -
The Hills Times
The Hills Timeshttps://thehillstimes.in/
Welcome to The Hills Times, your trusted source for daily news and updates in English from the heart of Assam, India. Since our establishment in 2000, we've been dedicated to providing timely and accurate information to our readers in Diphu and Guwahati. As the first English newspaper in the then undemarcated Karbi Anglong district, we've forged a strong connection with diverse communities and age groups, earning a reputation for being a reliable source of news and insights. In addition to our print edition, we keep pace with the digital age through our website, https://thehillstimes.in, where we diligently update our readers with the latest happenings day by day. Whether it's local events, regional developments, or global news, The Hills Times strives to keep you informed with dedication and integrity. Join us in staying ahead of the curve and exploring the world through our lens.
Latest news
- Advertisement -
Related news
- Advertisement -